Cutting-edge issues in coronary disease and the primary antiphospholipid syndrome.

@article{Gualtierotti2013CuttingedgeII,
  title={Cutting-edge issues in coronary disease and the primary antiphospholipid syndrome.},
  author={Roberta Gualtierotti and Martina Biggioggero and Pier Luigi Meroni},
  journal={Clinical reviews in allergy & immunology},
  year={2013},
  volume={44 1},
  pages={51-6}
}
Antiphospholipid syndrome (APS) is the most frequent cause of venous and arterial thrombotic events in young patients. The brain arterial tree is primarily affected, but coronary ischemic manifestations are also relatively frequent. Coronary involvement was suggested to be closely related to the accelerated atherosclerosis linked to the underlying disease in APS associated to systemic autoimmune diseases, in particular, systemic lupus erythematosus. However, arterial ischemic events can occur… CONTINUE READING